Rodent Model for Neurodegenerative Disorders
Summary
European Patent Office published patent application EP4030896A1 for Neuro-Bio Ltd's rodent model for neurodegenerative disorders. The patent covers classifications A01K 67/027, C07K 14/47, and C12N 9/18. The application designates all major EPO member states including DE, FR, GB, IT, ES, NL, and 29 others.
What changed
The EPO published patent application EP4030896A1 filed by Neuro-Bio Ltd for a rodent model useful in studying neurodegenerative disorders. Inventor is Susan Greenfield. The patent covers specific biological compositions and methods related to C07K 14/47 (polypeptides) and C12N 9/18 (enzymes). The designation extends to 35 European states including AT, BE, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.\n\nThis is a routine patent publication notice with no compliance obligations for third parties. Parties developing similar animal models or working in the neurodegenerative disease research space should review this publication for potential freedom-to-operate considerations. No action is required unless conducting commercial activities that may infringe the claims once granted.
Source document (simplified)
RODENT MODEL FOR NEURODEGENERATIVE DISORDERS
Publication EP4030896A1 Kind: A1 Mar 25, 2026
Applicants
Neuro-Bio Ltd
Inventors
GREENFIELD, Susan
IPC Classifications
A01K 67/027 20060101AFI20250819BHEP C07K 14/47 20060101ALI20250819BHEP C12N 9/18 20060101ALI20250819BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.